|

- 积分
- 237
- 威望
- 237
- 包包
- 1133
|
回复 s02260441 的帖子/ c( P( m. `! Z. B) W. Q; I2 s
! [4 H8 A# {/ O" B0 {& [
Published in final edited form as:; Z+ H5 Z7 f! p
Biol Blood Marrow Transplant. 2009 December ; 15(12): 1596–1602. doi:10.1016/j.bbmt.2009.08.009.: ~5 @; f0 k: i. n {* V$ \
2 [! r/ v# m& R9 J$ Q# r' H) y
A “No-wash” Albumin-Dextran Dilution Strategy for Cord Blood3 U; C/ n* N7 [- U- ~% g$ ?. H3 k! C
Unit Thaw: High Rate of Engraftment and a Low Incidence of
a- t% h U0 Y+ uSerious Infusion Reactions
1 Q( D5 b, x2 M% t; I B( y; K' Q4 y" G- T9 R E% p$ Z0 Z
Abstract7 D0 w4 G! ]6 ~! R6 ?7 ~ }
Preparation of cord blood (CB) units for infusion by albumin-dextran dilution without
7 r3 z0 H+ b8 Ecentrifugation may be advantageous for adult patients to minimize cell loss and, unlike a bedside
0 R( h9 b! I/ w- I1 x2 T+ I0 \% Zthaw, is still conducted in the controlled laboratory environment. Therefore, we studied CB: f* t* @5 ~8 e0 K5 O0 g
transplantation (CBT) using this technique in 54 consecutive CBT recipients ≥20 kg. Patients
1 g% }0 i7 x* X% r6 J; t[median age 42 years (range 7–66); median weight 71 kg (range 24–109)] were transplanted for E7 _) L( \) B' |
high-risk hematological malignancies with ablative (n=35) or non-ablative (n=19) conditioning
) `: }. {8 |5 z" P* z2 i: G4 jand 4–6/6 human leukocyte antigen (HLA)-matched double unit grafts. One hundred and seven: I8 ^0 q( p( ^9 G
units were thawed with dilution whereas 1 red blood cell (RBC) replete unit was washed. A 5:1 j4 c1 L* B4 Z) A1 ~
dextran 40/ 25% albumin solution was used. RBC depleted units (n=104) were diluted ≥5.5 fold9 m y9 r5 }/ o8 b* Q
[median final volume 200 ml (range 200–500)] whereas RBC replete units (n=3) were diluted ≥4
7 ?! s, u# l2 b0 s5 G; m0 ]0 F6 |, rfold [median final volume 400 ml (range 400–535)]. Total nucleated cell (TNC) recovery was
' z% F8 \) [: b, W5 N86%; the median infused TNC dose was 2.17 × 107/kg/unit. While 35 patients (65%) had a total of
- L9 d9 v6 W4 u5 b0 j$ A45 infusion reactions (6 nausea, 31 hypertension, 3 pain, 1 rigors/fever, 2 transient hypoxia, 2* q1 J* _/ ^. Y
renal impairment) requiring additional therapy, there were no infusion-related serious adverse
, }, B- F, k: I) vevents, and reactions were not related to DMSO dose/kg. Cumulative incidence of sustained donor" w0 b( y$ R& P" s
engraftment was 94% (95%CI: 87–100) with neutrophil recovery occurring at a median of 25 days; x" R3 L$ D: o( C
(range 13–43) in ablative and 10 days (range 7–36) in non-myeloablative recipients. CB thaw with8 m( d2 m7 B! X- H
albumin-dextran dilution reduces unit manipulation, and minimizes cell loss, speeds time to
. L& B2 c! Y9 ~* R8 rinfusion, is associated with a tolerable infusion reaction profile, and a high rate of sustained
5 P& c- O8 f. S2 P4 tengraftment in CBT recipients ≥20 kg.1 B2 E5 z7 B- e5 s" h
9 m6 R1 C9 g$ i7 k
' k$ h. o- l: }% ^1 } |
-
总评分: 威望 + 1
包包 + 5
查看全部评分
|